首页> 外文期刊>British Journal of Clinical Pharmacology >Minimising harm: human variation and adverse drug reactions (ADRs).
【24h】

Minimising harm: human variation and adverse drug reactions (ADRs).

机译:最小化危害:人为变异和药物不良反应(ADR)。

获取原文
获取原文并翻译 | 示例
       

摘要

'First, do no harm' - great advice to aspiring physicians throughout most of human history, but with the discovery of effective drugs in the twentieth century, no longer tenable as it stands. We could not get to first base in treating leukaemias, infections, cardiovascular disease, diabetes and so on if we were not prepared to accept an element of risk. It is the balance between benefit and harm that is key, rather than an unachievable ideal of absolute safety. But quantifying the probability of harm is problematic - at least for Rumsfeld's 'unknown unknowns'.The slogan 'Dis-taval - the safe hypnotic' adorned the drug company calendar in my father's consulting room: 'safe' in the sense that when taken in overdose it was less likely to prove fatal than barbiturates, which were the market-leading hypnotics in the nineteen fifties.
机译:“首先,不要伤害”-在整个人类历史上对有抱负的医生都提供了很好的建议,但是随着20世纪有效药物的发现,这种观点已不再成立。如果我们不准备接受危险因素,我们将无法在治疗白血病,感染,心血管疾病,糖尿病等方面立足。关键是利益与伤害之间的平衡,而不是绝对安全性无法实现的理想。但是量化危害的可能性是有问题的-至少对于拉姆斯菲尔德(Ramsfeld)的``未知未知数''来说是这样的口号``毁灭-安全的催眠药''在我父亲的诊疗室里装饰着制药公司的日历:过量使用它比巴比妥类药物更没有致命危险,后者是19世纪50年代市场上领先的催眠药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号